Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott G Hansen

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Nature|September 13, 2013
Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Science (New York, N.Y.)|May 25, 2013
Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigmsScott G Hansen, Jonah B Sacha, Colette M Hughes, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunityClaire E Otero, Sophia Petkova, Martin Ebermann, et al.
Science Translational Medicine|July 19, 2019
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challengeScott G Hansen, Emily E Marshall, Daniel Malouli, et al.
Nature Medicine|September 11, 2012
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccinesYoshinori Fukazawa, Haesun Park, Mark J Cameron, et al.
Nature|June 22, 2017
Addendum: Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Science Immunology|March 26, 2021
Cytomegaloviral determinants of CD8<sup>+</sup> T cell programming and RhCMV/SIV vaccine efficacyDaniel Malouli, Scott G Hansen, Meaghan H Hancock, et al.
Nature Communications|January 30, 2025
Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunityClaire E Otero, Sophia Petkova, Martin Ebermann, et al.
Science Immunology|June 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccineScott G Hansen, Meaghan H Hancock, Daniel Malouli, et al.
Nature Microbiology|January 30, 2026
Initial sites of SIV rebound after antiretroviral treatment cessation in rhesus macaquesBrandon F Keele, Afam A Okoye, Taina T Immonen, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Nature|September 13, 2013
Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Science (New York, N.Y.)|May 25, 2013
Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigmsScott G Hansen, Jonah B Sacha, Colette M Hughes, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunityClaire E Otero, Sophia Petkova, Martin Ebermann, et al.
Science Translational Medicine|July 19, 2019
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challengeScott G Hansen, Emily E Marshall, Daniel Malouli, et al.
Nature Medicine|September 11, 2012
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccinesYoshinori Fukazawa, Haesun Park, Mark J Cameron, et al.
Nature|June 22, 2017
Addendum: Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Science Immunology|March 26, 2021
Cytomegaloviral determinants of CD8<sup>+</sup> T cell programming and RhCMV/SIV vaccine efficacyDaniel Malouli, Scott G Hansen, Meaghan H Hancock, et al.
Nature Communications|January 30, 2025
Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunityClaire E Otero, Sophia Petkova, Martin Ebermann, et al.
Science Immunology|June 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccineScott G Hansen, Meaghan H Hancock, Daniel Malouli, et al.
Nature Microbiology|January 30, 2026
Initial sites of SIV rebound after antiretroviral treatment cessation in rhesus macaquesBrandon F Keele, Afam A Okoye, Taina T Immonen, et al.
Pageof 9